Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

The effect of aerobic and resistance training in patients with type 2 diabetes on vitamin D (Diavitex)

A study protocol

Bibliographic Data

ID22083374
AuthorsElnaz Dardashtipour (Universitat Ramon Llull), Sílvia Canivell (0000-0002-0280-5035, Institut Català de la Salut), Mohammad Ali Azarbayjani (Islamic Azad University South Tehran Branch), Andrea Fuente-Vidal (0000-0002-4274-1515, Universitat Ramon Llull), Aina Surroca (Universitat Ramon Llull), Pilar Gascón (0000-0003-3036-3753, Universitat Ramon Llull), Concepció Mestres (Universitat Ramon Llull), Alícia Antón (Universitat Ramon Llull), Maria José Peña-Mateo (Institut Català de la Salut), Elena Carrillo-Álvarez (0000-0002-3834-7101, Universitat Ramon Llull), Anna Maria Canudas, Myriam Guerra-Balic (0000-0002-9197-3179, Universitat Ramon Llull), Joel Montané (0000-0001-9531-9580, Universitat Ramon Llull)
Year2026
Volume13
Pages1674293-1674293
Publication date2026-01-05
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2025.1674293
PMID41561835
OpenAlexW7118182064
LanguageEN
References cited30

Introduction Aerobic and resistance training can effectively improve clinical management in people with type 2 diabetes (T2D). Low vitamin D (VitD) levels are associated with T2D risk and metabolic disturbances, and may help reduce this risk, particularly in individuals with low VitD levels. In this line, many individuals with T2D, who may also be older adults or have osteoporosis, regularly include VitD treatment in their healthcare routines. Although the impact of exercise has been extensively studied, its effect on diabetic patients taking VitD remains limited. The aim of this study is to investigate the effect of aerobic and resistance training on clinical parameters in patients with T2D already taking VitD. Methods The DIAVITEX study is a randomized controlled superiority trial, with four parallel arms, including 80 individuals with T2D. Patients will be selected at the Primary Care Centers and stratified according to their pre-existing VitD treatment. Participants will subsequently be randomized to the exercise intervention or control as follows: Group 1, Exercise + VitD users ( n = 20); Group 2, Exercise + VitD non-users ( n = 20); Group 3, VitD only (no exercise) ( n = 20); and Group 4, Control (No VitD & No Exercise) ( n = 20). In this study, a sarcoplasm-stimulating training program will be carried out online, three sessions per week for a total of 16 weeks. Before and after the physical activity subjects will perform fitness and blood tests. Nutritional education programs will be provided to normalize their diets for study consistency. The primary endpoint of the trial is the change in HOMA-IR index from baseline to week 16. Secondary endpoints include changes in HbA1c, lipid profile, body composition, and inflammatory biomarkers. Discussion Expected improvements in insulin resistance, glycated hemoglobin, lipid profile, and inflammatory markers are anticipated following a 16-week regimen of exercise in patients with T2D on VitD. Clinical trial registration The study was registered on September 21, 2024, with the identifier number NCT06081387, https://clinicaltrials.gov/study/NCT06081387

Diabetes mellitus · Insulin resistance · Metformin · Resistance training · Type 2 diabetes · Vitamin D and neurology · HIV-related health complications and treatments · Physical Activity and Health · Vitamin D Research Studies

  • Physical Activity/Exercise and Diabetes

    Open Access•Sheri R Colberg, Ronald J Sigal et al.•Diabetes Care•2016

  • Development and Validation of a Food Frequency Questionnaire in Spain

    José M Martín-Moreno, Peter Boyle et al.•International Journal of…•1993

  • Decreased bioavailability of vitamin D in obesity

    Open Access•Jacobo Wortsman, Lois Y Matsuoka et al.•American Journal of Clinical…•2000

  • Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050

    Open Access•Kanyin Liane Ong, Lauryn K Stafford et al.•The Lancet•2023

  • Validity and reliability of the Spanish Version of the Psychological General Well-Being Index

    Open Access•Xavier Badia, F Guti rrez et al.•Quality of Life Research•1996

Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae